Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Flatulence
ADR ID BADD_A01662
ADR Hierarchy
07      Gastrointestinal disorders
07.01      Gastrointestinal signs and symptoms
07.01.04      Flatulence, bloating and distension
07.01.04.002      Flatulence
Description A disorder characterized by a discharge of excessive gas from the lower GI tract. [CTCAE] Production or presence of gas in the gastrointestinal tract which may be expelled through the anus. [MeSH]
MedDRA Code 10016766
MeSH ID D005414; D014919
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Abdominal wind | Air in intestines | Air in stomach | Excessive flatulence | Flatulence | Flatulence, eructation, and gas pain | Flatus | Flatus increased | Gas | Gas evolution in intestine | Gas in stomach | Gas pain | Gaseousness | Meteorism | Pain gas | Tympanites | Wind | Malodorous flatulence
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01508Mycophenolic acid--
BADD_D01511Nabumetone--
BADD_D01512Nadolol--
BADD_D01524Naloxegol oxalate--
BADD_D01527Naltrexone--
BADD_D01528Naltrexone hydrochloride--
BADD_D01533Naproxen0.000048%
BADD_D01534Naproxen sodium--
BADD_D01537Natalizumab--
BADD_D01546Nefazodone--
BADD_D01550Nelfinavir mesylate--
BADD_D01553Neostigmine--
BADD_D01554Neostigmine methylsulfate--
BADD_D01559Niacin--
BADD_D01563Nicotinate--
BADD_D01564Nicotine0.001692%
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.001589%
BADD_D01570Nisoldipine--
BADD_D01571Nitazoxanide--
BADD_D01576Nitrofurantoin--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01582Nizatidine--
BADD_D01585Norethindrone--
BADD_D01586Norethindrone acetate--
BADD_D01587Norfloxacin--
BADD_D01592Obeticholic acid0.007402%
BADD_D01595Octreotide acetate--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine--
The 15th Page    First    Pre   15 16 17 18 19    Next   Last    Total 24 Pages